Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BE Group interim report January – June 2024

Second quarter · Net sales decreased by 10% to SEK 1,272 M (1,406) · The underlying operating result amounted to SEK 18 M (33) · The operating result amounted to SEK 11 M (26), including inventory losses of SEK -7 M (-7) · Result after tax amounted to SEK 1 M (19) · Cash flow from operating activities amounted to SEK 21 M (132) · Earnings per share amounted to SEK 0.13 (1.47) Statement from the CEODuring the second quarter net sales decreased by 10 percent to SEK 1,272 M (1,406), which is mainly explained by lower market prices. The lower pricing has affected the

Form 8.3 - Wood Group (John) Plc

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   +----------------------------------------------------------+-------------------+|(a) Full name of discloser: |Ninety One UK Ltd |+----------------------------------------------------------+-------------------+|(b) Owner or controller of interests and short positions |  ||disclosed, if different from 1(a):

New UK Labour government will focus on healthtech and dementia treatment as part of UK healthcare reform

Copenhagen, Denmark, 12 July 2024 – Brain+ A/S (Nasdaq First North: BRAINP) · Building a National Health Service (NHS) fit for the future is a top priority for the new UK Labour government · As part of their healthcare plan, Labour wants to harness the power of healthtech to offer better disease prevention and management and put Britain at the forefront of dementia treatment    · Brain+’ pipeline of healthtech solutions for better dementia management have offerings perfectly aligned with the new political healthcare agenda in the UK · The planned launch of the CST-

Half-year report January – June 2024

· Rental income increased 7 per cent to SEK 2,561 million (2,386). · Profit from property management increased 4 per cent to SEK 1,240 million (1,187). · Operating cash flow increased 7 per cent to SEK 1,251 million (1,166). · Changes in the value of properties amounted to SEK -334 million (-2,954). · Changes in the value of financial instruments amounted to SEK -96 million (-76). · Profit after tax for the period amounted to SEK 670 million (-1,517). · The market value of the properties amounted to SEK 84,126 million (85,071). · During the period, SEK 1,625 million (1,

First Patient in Biosergen Clinical Trial Treating with BSG005 for Life Threatening Fungal Infection

Stockholm, Sweden – July 12, 2024 – Biosergen AB (“Biosergen”) is pleased to announce that the first patient suffering from an invasive fungal infection has been dosed with BSG005 as rescue therapy.‘Today marks a significant milestone as the first patient has received the first dose of our lead candidate BSG005. The goal with the study is to increase survival rates for these very ill patients with difficult to treat fungal strains or/and with resistance to current antifungal treatment. There is a significant unmet medical need for the many millions of people infected with and dying from

Publishing of Lindex Group’s Half-year Financial Report for January–June 2024

LINDEX GROUP plc, Press release 12.7.2024 at 11:00 EEST Lindex Group plc will publish its Half-year Financial Report for January–June 2024 on Friday 19 July 2024 at 8:30 EEST. A press and analyst briefing will be held in English the same day at 10:00 EEST as a live webcast that can be followed via this link . The recording and presentation material will be available on the company's website after the event. Further information:Group Communications, MediaDeskMon–Fri 9–16 EESTtel. +358 50 389 0011info@stockmann.

Alfa Laval invites investors, analysts and financial media to its Capital Markets Day on 21 November 2024

This year we will take the Capital Markets Day to southern Europe and visit our heat exchanger manufacturing site in San Bonifacio in Italy.The in-person event will start with a dinner on 20 November, followed by a full day at one of our newest manufacturing sites for brazed heat exchangers on 21 November. This year’s CMD will focus on Alfa Laval’s role in the ongoing energy transition, with emphasis on the Energy division. During the day, members of the executive management will outline the strategy to support this transition as well as a deep dive into specific business areas and the

Interim report, Q2 2024 - Aixia Group AB (publ)

Mölndal                                                                                      2024-07-12 Group financial overview All amounts in 2024 2023 2024 2023 2023TSEKGroup financial Second Second Firstquarters Firstquarters Full yearoverview quarter quarterNet sales 66 815 22 964 272 411 45 210 107 809EBITDA 5 270 -1 234 22 215 -840 935Earnings (EBIT) 3 868 -2 235 19 294 -2 785 -4 047Earnings after 2 921 -2 327 14

Press invitation: Vattenfall to present interim report for January-June 2024 on July 19

Vattenfall's interim report for January to June 2024 will be published on Friday July 19 at 08.00 CEST on group.vattenfall.com. A live audiocast for analysts and media will start at 09.30 CEST.Vattenfall’s President and CEO Anna Borg and CFO Kerstin Ahlfont will present the results together with Senior Vice President Strategic Development Andreas Regnell. The presentation and following Q&A session will be held in English. Link: Vattenfall January-June 2024 

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 157 – 12 JULY 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 96/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Communications & Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

NIB and Ericsson continue to advance wireless technology through R&D

The Nordic Investment Bank (NIB) and the Swedish telecommunications company Ericsson have signed a USD 108.16 million (EUR 100 million) loan agreement for the development of enhanced wireless technology.This is NIB’s second loan for Ericsson’s investments in research and development (R&D) between 2023 and 2025. The investments support the company’s plan to reach net zero targets by 2040 through reduced energy consumption in the mobile networks globally. The new loan takes NIB’s overall financing to Ericsson to over EUR 800 million. Since 1979, the Bank has provided the company with

WindowMaster International A/S wins Contract for new Canadian Research Facility

Investor News No. 033 - 2024WindowMaster has been awarded a purchase order to supply all window automation and control hardware for the natural ventilation system of the Centre for Addiction and Mental Health (CAMH) Research & Discovery Centre project. The natural ventilation system by WindowMaster will improve indoor air quality and occupant comfort at the new research facility in Toronto, Canada. The project includes approximately 390,000sf (36,000m[2]) of new construction, replacing CAMH’s existing Queen Street facility. Construction is due to be completed in 2027.

Digitalization partnership streamlines sterile workflow in Japan

A renowned third-party sterilization service provider in Japan, medical bear, has forged a strategic partnership with Getinge in a transformation program focusing on digitalization of the company’s sterile supply flow. This collaboration heralds a new era in the digitalization of sterile supply flows, setting a benchmark for innovation in Japan's healthcare sector. The heart of this transformation is the integration of Getinge’s T-DOC sterile supply management system into medical bear’s operations. This cutting-edge digital solution has improved the company's workflow, elevating

MilDef recruits VP Nordics and strengthens Group Management

MilDef has decided to recruit Magnus Hagman as Vice President Nordics. Magnus has both a solid industry experience and a well-documented expertise in internationall business development and sales. He comes most recently from a role as Head of Sales and Marketing at Carmenta, where he has been active since 2022. Prior, Magnus was employed in various roles at the defence company SAAB for ten years. Magnus Hagman will be part of the company's Group Management and report directly to the CEO. He will take up his position no later than 16 September 2024."I am pleased to start working with Magnus

Safeture Partners with Eigenrac to Enhance ESG Initiatives in Complex Environments

Safeture, a Swedish global leader in people risk management solutions, is proud to announce a new strategic partnership with Eigenrac. This collaboration aims to integrate and enhance Environment, Social, and Governance (ESG) programs in complex environments, utilizing Safeture’s innovative technology and Eigenrac’s expertise in sustainable development and risk management.Eigenrac, established in 2020, has quickly distinguished itself in building nationalized sustainable platforms for ESG programs. Leveraging internationally recognized intelligence and risk management methodologies,

Interim Report Second Quarter of 2024

Second Quarter (April–June 2024) · Net sales amounted to TSEK 146,194 (110,328), which is an increase of 32.5 % compared to the same period last year. · The gross margin amounted to 53.4 % (57.4). · Operating profit before depreciation (EBITDA) amounted to TSEK 41,712 (21,232), which corresponds to an operating margin before depreciation of 28.5 % (19.2). · Operating profit (EBIT) amounted to TSEK 24,906 (7,947), which corresponds to an operating margin of 17.0 % (7.2). · Earnings per share before dilution amounted to SEK 1.69 (0.53). (Comparative figures in parentheses

CLS announces last day of trading with BTU and first day of trading in warrants of series TO 7

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEELAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, RUSSIA, BELARUS OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE UNLAWFUL OR DEMAND ADDITIONAL REGISTRATION OR OTHER MEASURES. PLEASE REFER TO “IMPORTANT INFORMATION” IN THE END OF THIS PRESS RELEASE.   Clinical Laserthermia Systems AB:s ("CLS" or the “Company") rights issue is now registered with the Swedish Companies

Skanska allocated an additional GBP 50M, about SEK 660M, towards works on the high-speed railway HS2 in UK

Skanska, as part of the Skanska Costain STRABAG joint venture, has been allocated an additional GBP 50M, about SEK660M, under the existing contract with HS2 Ltd towards works on phase one of the new high-speed railway in the UK. This will be included in the order bookings for Europe in the third quarter of 2024.The award relates to planned and agreed changes to the scope of works under the contract. The total contract, now valued at approximately GBP 1.425 billion, about SEK 19.0 billion to Skanska, involves the design and construction of major tunnels in the southern section of the

Interim Report 1 January – 30 June 2024

· 45% sales growth despite transformation of sales organization · Additional SEK 12m in annual cost savings identified · Pause of EPIC-Knee trial to the advantage of other initiatives“We have started considerably faster in the US than what we have seen in any other market. For example, during the second quarter, the US market represents approx. 45% of the turnover in Germany, which is by far our largest market to date. In other words, we follow our strategy. We also see good opportunities to continue the beaten track at an ever-increasing speed. We will continue with our commercial

Biokraft International AB (PUBL) confirms redemption of its senior secured floating rate green bonds due 2026 and announces that interim reports no longer will be published

This notice is made in respect of Biokraft International AB (publ) (previously Scandinavian Biogas Fuels International AB (publ)) (“Biokraft”) up to SEK 1,200,000,000 senior secured floating rate green bonds due 2026 (ISIN: SE0015812441) (the “Bonds”). Biokraft has on 11 July 2024 settled the full repayment of the Bonds. As a consequence of the delisting of the shares in Biokraft from Nasdaq First North Premier Growth Market and the Bonds being delisted from Nasdaq Stockholm and redeemed in full, the requirement to issue interim reports is no longer applicable to Biokraft. Against the

Sleep Cycle AB (publ) invites you to a presentation of the second quarter of 2024

Gothenburg, Sweden, 12 July, 2024 – Sleep Cycle AB (publ), a global leader in AI-driven sleep analysis, will on the 26 of July, at 9:30 CET, present the interim report for April-June 2024 for shareholders, media and other stakeholders. Participants will be able to follow the presentation via webcast.Sleep Cycles CEO Erik Jivmark and CFO & Head of IR Elisabeth Hedman will present the report, which will be followed by a Q&A session. The presentation will be held in English. If you wish to participate via webcast please use the link below. Via the webcast you are able to ask written

Italian filters distributor to become part of Atlas Copco Group

Nacka, Sweden, July 12, 2024: Easy Filtration SRL (“Easy Filtration”), an Italian company that distributes process filters and associated services, will become part of Atlas Copco Group.Easy Filtration, located in Milan, was founded in 2013. The company has 9 employees and provides filter cartridges for air, gas and process liquids, filter housings and clean-in-place systems. The main customer groups are present within the industrial coatings, chemical, cosmetics and pharmaceutical sectors. “This acquisition will expand our possibilities to cater for our customers’ needs in Italy, both

Nexam Chemical Holding AB (publ) Interim Report 1 January – 30 June 2024

Increasing sales, improved coverage ratio and lowered break-evenSecond quarter at a glance Significant events during the quarter: · Sales increased by 29% compared to the corresponding quarter in 2023 and the gross margin increased from 43% to 46%. Sequentially, sales increased by 1% compared to the first quarter of 2024. · EBITDA increased to kSEK 2,622, which is a sequential increase of 19% compared to the first quarter of 2024. · Sales for Performance Masterbatch increased by 19% compared to the corresponding quarter in 2023 and Performance Chemical increased by 45%. ·

There are no items matching the current filter
There are no more items matching the current filter
Back to top